Small Molecules
11 February 2014
Cerulean Announces First Patient Dosed in Phase 2 Clinical Trial of CRLX101 in Combination with Avastin® in Relapsed Ovarian Cancer11 February 2014
Ultragenyx Announces Initiation of Phase 2 Study for Patients with Long-Chain Fatty Acid Oxidation Disorders11 February 2014
Ario Pharma Commences Phase IIa Trial of TRPV1 Inhibitor for Cough Associated with Chronic Obstructive Pulmonary Disease11 February 2014
Kareus Therapeutics SA Announces Phase I Clinical Trial Initiation for Treatment of Diabetes11 February 2014
Omeros Reports Additional Positive Phase 1 Clinical Data for OMS824 for the Treatment of Cognitive Disorders11 February 2014
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C11 February 2014
Lipocine Announces First Patient Dosed in Phase 3 Study for Oral Testosterone Replacement Therapy10 February 2014
e-Therapeutics Begins Phase I Study of Oral Formulation of Anti-Cancer Compound ETS2101 with Healthy Volunteers6 February 2014
REGiMMUNE Begins Enrollment for Phase II Clinical Trial for Graft Versus Host Disease4 February 2014
IntelGenx and RedHill Biopharma Receive Complete Response Letter From FDA for VersaFilm(TM) Oral Film Product for Acute Migraines4 February 2014
Rockwell Medical Completes Long-Term Safety Study for Iron Maintenance Drug Triferic(TM)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports